Numeric Investors’s Alder Biopharmaceuticals ALDR Stock Holding History

Numeric Investors’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$169K	Buy	+14,800	New	+$165K	﹤0.01%	1034
2015 Q4	–	Sell	-100,400	Closed	-$3.29M	–	1191
2015 Q3	$3.29M	Buy	100,400 +8,400	+9%	+$357K	0.04%	307
2015 Q2	$4.87M	Sell	92,000 -65,929	-42%	-$2.4M	0.06%	258
2015 Q1	$4.56M	Buy	+157,929	New	+$4.33M	0.06%	265

Other funds holding ALDR

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Numeric Investors's ALDR Position: Q4 2017 in Review

Numeric Investors opened a new position in Alder Biopharmaceuticals (ALDR) in Q4 2017: 14,800 shares worth $169K. The stake represents ﹤0.01% of the portfolio and ranks #1034 among its holdings. This is a return to the name: Numeric Investors previously reported a position in ALDR as recently as Q3 2015.

Numeric Investors first reported a position in ALDR in Q1 2015 and has held it in 4 quarters since. The position peaked at $4.87M in Q2 2015. 140 funds tracked by Wall St. Rank hold ALDR as of Q4 2017.

Numeric Investors held 14,800 shares of Alder Biopharmaceuticals worth $169K as of Q4 2017.
Alder Biopharmaceuticals was a new Numeric Investors position in Q4 2017.
Alder Biopharmaceuticals made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #1034 holding.
Numeric Investors first reported a position in Alder Biopharmaceuticals in Q1 2015 and has held it in 4 quarters since.
Numeric Investors's Alder Biopharmaceuticals position peaked at $4.87M in Q2 2015.
140 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.